Skip to main content
. 2023 Jun 22;79(8):1131–1141. doi: 10.1007/s00228-023-03525-0

Table 1.

The primary outcome sum pain intensity over 6 h (SPI), SPI for each sex, baseline pain at drug intake, number needed to treat (NNT), number needed to prevent rescue drug intake (NNTp), and rescue drug details for each trial group are shown. Present pain was scored on numerical rating scales (0–10 NRS) ranging from

Paracetamol 1000 mg
Ibuprofen 400 mg
Paracetamol 1000 mg
Codeine 60 mg
Paracetamol 1000 mg
Ibuprofen 400 mg
Codeine 60 mg
Placebo
n = 50 n = 50 n = 50 n = 50
F/M = 25/25 F/M = 28/22 F/M = 29/21 F/M = 26/24
Pain at drug intake (NRS)
Median 6.0 5.0 5.5 5.0
(Q1, Q3) (4.8, 7.0) (4.0, 6.0) (4.0, 6.3) (4.0, 6.3)
Median (females) 6.0 5.5 6.0 6.0
(Q1, Q3) (5.0, 7.0) (4.3, 7.0) (5.0, 7.0) (4.8, 7.0)
Median (males) 6.0 5.0 5.0 5.0
(Q1, Q3) (4.0, 7.0) (4.0, 6.0) (4.0, 6.0) (4.0, 6.0)
Mean 6.0 5.5 5.5 5.5
(95% CI) (5.6, 6.4) (5.1, 5.9) (5.1, 5.9) (5.1, 5.9)
Mean (females) 6.2 5.8 5.8 5.7
(95% CI) (5.6, 6.8) (5.2, 6.4) (5.3, 6.3) (5.2, 6.3)
Mean (males) 5.7 5.2 5.2 5.3
(95% CI) (5.2, 6.3) (4.7, 5.7) (4.6, 5.8) (4.8, 5.7)
Primary variable
Sum pain intensity (SPI)
Median 44.5 62.5 39.5 89.0
(Q1, Q3) (30.8, 56.5) (40.0, 84.3) (26.8, 56.3) (75.0, 116.3)
Mean 47.6 65.2 43.5 94.3
(95% CI) (42.2, 53.0) (56.0, 74.4) (37.7, 49.3) (87.7, 100.9)
Median (females) 44.0 71.5 49.0 90.0
(Q1, Q3) (33.5, 55.0) (53.5, 92.5) (33.0, 66.0) (80.3, 119.3)
Mean (females) 46.2 73.3 50.7 95.7
(95% CI) (39.5, 53.0) (61.1, 85.5) (42.7, 58.7) (86.0, 105.4)
Median (males) 47.0 43.0 29.0 89.0
(Q1, Q3) (28.0, 60.5) (33.8, 69.3) (26.0, 39.5) (74.3, 115.8)
Mean (males) 48.9 54.8 33.6 92.8
(95% CI) (40.1, 57.8) (41.0, 68.6) (26.6, 40.6) (83.2, 102.3)
Secondary variables
NNT 1.8 2.6 1.7 n/a
NNTp 1.5 5.0 1.7 n/a
Rescue drug intake
Patients/no tablets 4/6 28/51 8/12 38/85